—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Sonova H Ag (SOON.SW) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for SOON.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-09-25

DayWeekMonth3 months
SOON.SW+0.5%+3.9%+1.8%+25.5%
Surgical, Med Devices & Animal Health+0.2%+1.4%−3.7%—
HALO Growth 1000.0%+0.2%−7.6%—

Against the index: 3.7 pts ahead on the week, 9.4 pts ahead on the month; against its Surgical, Med Devices & Animal Health sleeve 5.5 pts ahead on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sector × region Health care in Europe: +0.1% week · −3.6% month · −4.6% quarter · −1.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-27
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against SOON.SW on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Sonova H Ag

SOON.SW in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Sonova designs, makes and sells hearing devices and related services, running through Hearing Instruments, Cochlear Implants and Lifestyle-Aligned segments. The Hearing Instruments arm covers Phonak, Unitron, Hansaton and Sennheiser branded aids and headsets plus audiological clinics under several retail names. The Cochlear Implants unit builds implantable hearing systems under the Advanced Bionics brand, and the Lifestyle-Aligned segment adds connected, AI-linked features to its devices. It sells directly through its own stores and wholesales to independent audiologists and retail chains worldwide, based in Stäfa, Switzerland.
Where it sits in the stack
Sonova sits in our HALO Growth 100, the growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve that groups regulated device makers built for steady, long-run demand. It carries no seat in Rubin, our AI build-out index; inside the healthcare sleeve it is a maker of devices that now embed AI features rather than a supplier into the chip or data-centre stack.
Who it is priced against
Its peer group covers surgical, med-device and animal-health names such as Intuitive Surgical, Stryker, IDEXX Laboratories, DexCom, Insulet, Globus Medical and Sartorius, grouped for their regulated moats and long compounding histories; the market also names Cochlear as a direct competitor in implants.
Why Closelooknet tracks it
Sonova holds a seat in the HALO Growth 100 and carries a Closelooknet score, with momentum the strongest of its seven modules and valuation the weakest; the diary has not logged a quote or mention for it yet.
What the diary watches
Whether the growth module recovers from its current low reading as new hearing and implant lines gain share, and whether the gap between momentum and valuation narrows or widens.

Sonova H Ag (SOON.SW) trades on the SW exchange in Switzerland, classified under Healthcare. Constituent of HALO Growth 100.

The Closelooknet company score reads 55/100 composite (momentum 86, quality 72, valuation 54) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 1.95%, annual · buybacks 63 m CHF in FY2026

Dividends and capital return

What SOON.SW pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 4.70 CHF per share · a 1.95% yield on the 2026-09-25 close 1 distribution, paid once a year 2026-09-25
  • Change on the year +6.8% against the prior twelve months prior twelve months 4.40 CHF per share
  • Last distribution 4.70 CHF per share as the price series records it, within days of the ex-date 2026-06-19
  • By calendar year 2024: 4.30 CHF (partial) · 2025: 4.40 CHF · 2026: 4.70 CHF to date first distribution recorded in the three-year window: 2024-06-13
  • Dividends paid, FY2026 262 m CHF 149% of earnings
  • Buybacks, FY2026 63 m CHF 0.4% of today's market value
  • Share count +1.3% in FY2026 19 m CHF of stock-based compensation in the year
  • Capital returned 325 m CHF · 54% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Sonova H Ag (SOON.SW)?

Sonova H Ag trades as SOON.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is SOON.SW in a Closelooknet index?

Yes — Sonova H Ag is a constituent of HALO Growth 100, as of 2026-09-26.

What is Sonova H Ag's Closelooknet composite score?

55 out of 100, with momentum 86, quality 72 and valuation 54 sub-scores, as of 2026-09-26. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does SOON.SW trade against its moving averages?

-0.9% at the close: Holding 3.3% off its 52-week high. As of 2026-09-24 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is SOON.SW doing against its Closelooknet index?

Over the past month Sonova H Ag is +1.8% against −7.6% for the HALO Growth 100 — 9.4 points ahead of its index, as of 2026-09-25. Its Surgical, Med Devices & Animal Health sleeve is −3.7% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does Sonova H Ag do?

Sonova designs, makes and sells hearing devices and related services, running through Hearing Instruments, Cochlear Implants and Lifestyle-Aligned segments. The Hearing Instruments arm covers Phonak, Unitron, Hansaton and Sennheiser branded aids and headsets plus audiological clinics under several retail names. The Cochlear Implants unit builds implantable hearing systems under the Advanced Bionics brand, and the Lifestyle-Aligned segment adds connected, AI-linked features to its devices. Its peer group covers surgical, med-device and animal-health names such as Intuitive Surgical, Stryker, IDEXX Laboratories, DexCom, Insulet, Globus Medical and Sartorius, grouped for their regulated moats and long compounding histories; the market also names Cochlear as a direct competitor in implants.

Where does Sonova H Ag sit in the AI build-out?

Sonova sits in our HALO Growth 100, the growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve that groups regulated device makers built for steady, long-run demand. It carries no seat in Rubin, our AI build-out index; inside the healthcare sleeve it is a maker of devices that now embed AI features rather than a supplier into the chip or data-centre stack. Sonova holds a seat in the HALO Growth 100 and carries a Closelooknet score, with momentum the strongest of its seven modules and valuation the weakest; the diary has not logged a quote or mention for it yet.

Does Sonova H Ag pay a dividend?

Sonova H Ag has paid 4.70 CHF per share over the last twelve months, paid once a year, a trailing yield of 1.95% on the 2026-09-25 close; the last distribution recorded in the price series was 4.70 CHF on 2026-06-19. In fiscal 2026 the company paid 262 m CHF in dividends and bought back 63 m CHF of its own shares, 54% of that year’s free cash flow. The share count rose 1.3% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for SOON.SW, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.